SEC 13F Intelligence

Hayek Kallen Investment Management / ABBV

Hayek Kallen Investment Management’s Abbvie Inc Position

Does Hayek Kallen Investment Management own Abbvie Inc (ABBV)? Yes32.9K shares worth $7M (+2.33% of its 13F portfolio) as of Q1 2026, down from 33.5K shares the prior filed quarter.

Position Value
$7M
Q1 2026
Shares
32.9K
% of Portfolio
+2.33%
Quarters Held
28
currently held

Position History ABBV

Reported value by quarter
Q4 ’18: $3MQ4 ’18Q1 ’19: $3MQ2 ’19: $2MQ3 ’19: $2MQ4 ’19: $3MQ4 ’19Q1 ’20: $2MQ3 ’20: $3MQ4 ’20: $3MQ1 ’21: $3MQ1 ’21Q2 ’21: $4MQ3 ’21: $4MQ4 ’21: $4MQ1 ’22: $5MQ1 ’22Q2 ’22: $5MQ3 ’22: $4MQ4 ’22: $5MQ1 ’23: $5MQ1 ’23Q2 ’23: $4MQ3 ’23: $5MQ4 ’23: $5MQ1 ’24: $6MQ1 ’24Q2 ’24: $6MQ3 ’24: $7MQ4 ’24: $6MQ1 ’25: $7MQ1 ’25Q2 ’25: $6MQ3 ’25: $8MQ1 ’26: $7Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 202632.9K$7M+2.33%
Q3 202533.5K$8M+2.45%
Q2 202533.6K$6M+2.12%
Q1 202532.9K$7M+2.54%
Q4 202433.5K$6M+2.16%
Q3 202433.1K$7M+2.32%
Q2 202433.1K$6M+2.12%
Q1 202433.0K$6M+2.30%
Q4 202332.9K$5M+2.13%
Q3 202332.6K$5M+2.17%
Q2 202332.7K$4M+1.88%
Q1 202332.2K$5M+2.32%
Q4 202232.1K$5M+2.39%
Q3 202232.6K$4M+2.06%
Q2 202232.1K$5M+2.14%
Q1 202232.7K$5M+1.96%
Q4 202132.9K$4M+1.59%
Q3 202132.5K$4M+1.60%
Q2 202132.2K$4M+1.52%
Q1 202132.0K$3M+1.56%
Q4 202031.8K$3M+1.65%
Q3 202031.1K$3M+1.52%
Q1 202030.8K$2M+1.57%
Q4 201929.9K$3M+1.53%
Q3 201930.0K$2M+1.42%
Q2 201930.4K$2M+1.40%
Q1 201931.6K$3M+1.65%
Q4 201832.7K$3M+2.16%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Hayek Kallen Investment Management’s full portfolio or all institutional holders of ABBV.